Cargando…

Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis

BACKGROUND: Studies assessing the effect of high dose tigecycline on severe infections are limited and remain controversial. OBJECTIVES: To assess systematically the effectiveness and safety of high dose tigecycline in the treatment of severe infections. METHODS: Pubmed, Web of Science, Embase, MEDL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zha, Lei, Pan, Lingling, Guo, Jun, French, Neil, Villanueva, Elmer V., Tefsen, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223407/ https://www.ncbi.nlm.nih.gov/pubmed/32006240 http://dx.doi.org/10.1007/s12325-020-01235-y

Ejemplares similares

Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
por: Zha, Lei, et al.
Publicado: (2021)

Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study
por: Zha, Lei, et al.
Publicado: (2023)

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
por: Wang, Jian, et al.
Publicado: (2017)

Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19
por: Zha, Lei, et al.
Publicado: (2021)

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019)

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
por: De Pascale, Gennaro, et al.
Publicado: (2020)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae
por: Zha, Lei, et al.
Publicado: (2022)

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review
por: Liu, Yang-Xi, et al.
Publicado: (2021)

Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae
por: Zha, Lei, et al.
Publicado: (2020)

Prevalence and factors associated with post-traumatic stress disorder in healthcare workers exposed to COVID-19 in Wuhan, China: a cross-sectional survey
por: Pan, Lingling, et al.
Publicado: (2021)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
por: Britt, Nicholas S., et al.
Publicado: (2014)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

Intra-abdominal infection after tumor surgery: tigecycline combined with β-lactam antibiotics versus tigecycline alone
por: Cai, Xinfeng, et al.
Publicado: (2023)

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016)

Acinetobacter Prosthetic Joint Infection Treated with Debridement and High-Dose Tigecycline
por: Vila, Andrea, et al.
Publicado: (2016)

Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia
por: Ray, Avik, et al.
Publicado: (2020)

Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
por: Amann, Lisa F., et al.
Publicado: (2022)

Bloodstream infection with pandrug-resistant Alcaligenes faecalis treated with double-dose of tigecycline
por: Hasan, Md Jahidul, et al.
Publicado: (2019)

Population Pharmacokinetics of Tigecycline: A Systematic Review
por: Zhou, Can-Can, et al.
Publicado: (2022)

Chances and challenges in China
por: Tefsen, Boris
Publicado: (2015)

Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis
por: Xia, Guolian, et al.
Publicado: (2020)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature
por: Fan, Qiaomei, et al.
Publicado: (2020)

Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report
por: Alsemari, Muhannad A., et al.
Publicado: (2020)

Tigecycline-induced sustained severe hypoglycemia: a case report
por: Chen, Yixin, et al.
Publicado: (2019)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?
por: LaSalvia, Mary T., et al.
Publicado: (2017)

Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI
por: Navalkele, Bhagyashri D., et al.
Publicado: (2016)

Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study
por: Lin, Chuwen, et al.
Publicado: (2023)

Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
por: Hoban, Daryl J, et al.
Publicado: (2015)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

High dose of tigecycline for extremely resistant Gram-negative pneumonia: yes, we can
por: Garnacho-Montero, José, et al.
Publicado: (2014)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f033qo9lhkec796k6qm39etqsv